Login / Signup

Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.

Mathias DamkjærKjell HåkanssonThomas KallemoseCharlotte Suppli UlrikNina Skavlan Godtfredsen
Published in: International journal of chronic obstructive pulmonary disease (2021)
We did not find any association between statin use and risk of AECOPD or all-cause mortality. The result adds to the evidence that an aggressive approach with statin treatment upfront is not beneficial in COPD, unless prescribed according to current guidelines for cardiovascular diseases.
Keyphrases